References
- Fa-rnstrand M, Karlsson I, Thuresson K. Fo-rsta ndshandikappade i psykiatrin. Lakartidn 1994;91:392–6.
- Go-stasson R. Psychiatric illness among the mentally retarded. Acta Psychiatr Scand 1985; Suppl 318;71.
- Gillberg C, Presson E, Grufman N, Themmer V. Psychiatric disorders in mildly and severely mentally retarded urban children and adolescents. Epidemiological aspects. Br J Psychiatr 1986;149:68–74.
- Borthwik Duffy S. Epidemiology and prevalence of psycho-pathology in people with mental retardation. J Consult Clin Psychol 1994;62:17–27.
- Scott S. Mental retardation. In: Rutter M, Taylor E, Hersov L, editors. Child and adolescent psychiatry; modern ap-proaches. Oxford: Blackwell Scientific Publications; 1994. p. 616–46.
- Gordon C, Rapoport J, Hamburger S. Differential response o seven subjects with autistic disorder to clomipramin and de-sipramin. Am J Psychiatry 1992;149:363–6.
- Markowitz P. Effects of fluoxetine on self-injurious behavior i the developmentally disabled: a preliminary study. J Clin Psy-chopharmacol 1992;12:27–31.
- Pies R, Popli A. Self-injurious behavior; pathophysiology and implication for treatment. J Clin Psychiatry 1995;56:580–8.
- Bodfish J. Diagnosis and fluoxetine treatment of compulsive disorder of adults with mental retardation. Am J Mental Re-tard 1993;98:360–7.
- Gedye A. Trazodone reduced aggressive and self injurious movements in a mentally handicapped male patient with autism. J Clin Psychopharmacol 1991;11:275–6.
- Kavoussi R, Liti J, Coccaro E. An open trial of setraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994;55:137–41.
- Fuller R. The influence of fluoxetine on aggressive behavior. Neuropsychopharmacology 1996;14:77–81.
- Rubey R, Johnson M, Emmanuel N, Lydiard B. Fluoxetine i the treatment of anger: an open clinical trial. J Clin Psychiatr 1996;57:398–401.
- Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:281–3.
- Rotschild A. Delirium: an SSRI-benzotropine adverse effect. J Clin Psychiatry 1994;56:537.
- Brown W, Harrison W. Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry 1995;56:30–4.
- Ratey J, Gordon A. The psychopharmacology of aggression: toward a new day. Psychopharmacol Bull 1993;29:65–73.
- Cohen S, Underwood M. The use of clozapine in a mentally retarded and aggressive population. J Clin Psychiatry 1994;55:440–4.
- Safferman A, Kane J, Aronowitz J, Gordon M, Pollack S, Liebermann J. The use of clozapine in neurologic disorders. J Clin Psychiatry 1994; Suppl B 55/9:98–101.
- Pary R. Clozapine in three individuals with mild mental retar-dation and treatment-refractory psychiatric disorders. Ment Re-tard 1994;32:323–7.
- Baldassarini R, Frankenburg F. Clozapine: a novel antipsy-chotic agent. New Engl J Med 1991;324:746–54.
- Gerlach J, Peacock L. Motor and mental side effects of cloza-pine. J Clin Psychiatry 1994; Suppl B 55/9:107–9.
- Rimo'n R, Kuoppasalmi K, Naukkarinen H, Lang S, Sandqvist A, Leinonen E. Clozapine decreases the level of anxiety and aggressive behavior in patients with therapy-refractory schizophrenia. Nord J Psychiatry 1994;48: 315–20.
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed., rev. (DSM-III-R). Wash-ington (DC): APA; 1987.
- Kyle'n G. Bega vning och bega vningshandikapp. Stockholm: Stiftelsen ALA; 1981. ALA-rapport 39/366 C.